Evaluation of therapeutic efficacy for globus patients; randomized controlled trial

Evaluation of therapeutic efficacy for globus patients; randomized controlled trial - Evaluation of therapeutic efficacy for globus patients; randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036046

Enrollment

100

Registered

2019-02-28

Start date

2013-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Globus

Interventions

Oral administration of Hangekobokuto Oral administration of Rikkunshito Oral administration of proton pump inhibitor (PPI)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients who were diagnosed as globus and agreed to participate in this trial.

Exclusion criteria

Exclusion criteria: The patients who didn't agree to participate in thes trial.

Design outcomes

Primary

Measure	Time frame
Evaluation with visual analogue scale about subjective symptoms of globus	—

Secondary

Measure	Time frame
Evaluation with questionnaires; depression (SDS), anxiety (STAI), gastro-esophageal reflux (FSSG)	—

Countries

Japan

Contacts

Public ContactKoichiro Wasano

Japanese redcross Shizuoka hospital Department of Otolaryngology

wasano@a5.keio.jp054-254-4311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026